Atrial fibrillation linked to increased hospitalization in heart failure patients

Jul 06, 2009

Patients with atrial fibrillation, common in those with advanced chronic heart failure, have an increased risk of hospitalization due to heart failure, according to new research from researchers at the University of Alabama at Birmingham (UAB). The findings, published in June in the European Heart Journal, also suggest that atrial fibrillation is not associated with an increased risk of death in heart failure patients, contradicting previous assumptions.

"Our findings show that the presence of in heart failure patients did not increase their risk of death, as has been previously suggested, but did increase the risk of hospitalization due to worsening heart failure," said Mustafa Ahmed, M.D., a physician-scientist at the UAB American Board of Internal Medicine Research Pathway Program and the study's lead investigator.

Atrial fibrillation is a condition with irregular heart rhythm and is often accompanied by increased .

"Importantly, atrial fibrillation significantly increased hospitalization due to heart failure only in patients not receiving a beta-blocker or drugs that block the beta-receptors in the heart but not in those receiving a beta-blocker," said Ali Ahmed, M.D., MPH, associate professor in the division of gerontology, geriatrics and palliative care medicine, director of UAB's Geriatric Heart Failure Clinic and the study's senior investigator. "In patients with heart failure and atrial fibrillation, beta-blockers, which help reduce heart rate, may be useful in reducing the risk of hospitalization due to worsening heart failure."

Ahmed and colleagues matched 487 pairs of heart failure patients with and without atrial fibrillation from the Beta-Blocker Evaluation of Survival Trial. All-cause mortality occurred in 38 percent of the patients with atrial fibrillation against 37 percent of patients without. However, 44 percent patients with atrial fibrillation were hospitalized for worsening over the course of the trial, against only 38 percent without.

Source: University of Alabama at Birmingham (news : web)

Explore further: WHO: Ebola moving faster than control efforts

add to favorites email to friend print save as pdf

Related Stories

Osteoporosis drug may be associated with irregular heartbeat

Apr 28, 2008

Alendronate, a medication used to prevent fractures in women with osteoporosis, may be associated with an increased risk of atrial fibrillation, a type of abnormal heart rhythm, according to a report in the April 28 issue ...

Osteoporosis drug fosamax linked to heart problem

Apr 28, 2008

Women who have used Fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according to research from Group Health ...

Big men more susceptible to atrial fibrillation

Apr 03, 2009

Older men who were big during their 20s face an increased risk of suffering from atrial fibrillation, or abnormal heart rhythm. New research from the Sahlgrenska Academy, University of Gothenburg, Sweden, reveals that height ...

Irregular heartbeat linked to genetic mutation, study shows

Feb 23, 2007

Every day for 10 years, a seemingly heart-healthy 53-year-old woman experienced rapid and irregular heartbeats. She had no personal or family history of hypertension or hyperthyroidism. She did not suffer from myocardial ...

Recommended for you

WHO: Ebola moving faster than control efforts

1 hour ago

An Ebola outbreak that has killed more than 700 people in West Africa is moving faster than the efforts to control the disease, the head of the World Health Organization warned as presidents from the affected ...

Quick blood test for malaria

1 hour ago

Siemens is working on a procedure that would allow blood to be routinely tested for malaria. Physicians normally diagnose the tropical disease by using a microscope to search for parasites in blood samples. ...

User comments : 0